Efficacy of combined hypo-fractionated radiotherapy and anti-PD-1 monotherapy in difficult-to-treat advanced melanoma patients

Information on the role of radiotherapy in anti-PD-1 monoclonal antibody-treated melanoma patients is limited. We report on a prospective cohort of advanced melanoma patients treated simultaneously with radiotherapy and anti-PD-1 therapy between 01/01/15 and 30/06/16. Tumor evaluations (RECIST 1.1)...

Descripción completa

Detalles Bibliográficos
Autores principales: Roger, Anissa, Finet, Adeline, Boru, Blandine, Beauchet, Alain, Mazeron, Jean-Jacques, Otzmeguine, Yves, Blom, Astrid, Longvert, Christine, de Maleissye, Marie-Florence, Fort, Magali, Funck-Brentano, Elisa, Saiag, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053300/
https://www.ncbi.nlm.nih.gov/pubmed/30034949
http://dx.doi.org/10.1080/2162402X.2018.1442166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053300/
https://www.ncbi.nlm.nih.gov/pubmed/30034949
http://dx.doi.org/10.1080/2162402X.2018.1442166

Ejemplares similares